Boothbay Fund Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.55M | Buy |
182,452
+37,134
| +26% | +$519K | 0.05% | 321 |
|
|
2025
Q1 | $1.96M | Buy |
145,318
+7,400
| +5% | +$99.8K | 0.05% | 340 |
|
|
2024
Q4 | $2.64M | Sell |
137,918
-8,831
| -6% | -$169K | 0.07% | 305 |
|
|
2024
Q3 | $3.34M | Buy |
+146,749
| New | +$3.34M | 0.08% | 293 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1681 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1753 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2319 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2331 |
|